Target intelligence / Profile preview

RPL17-C18orf32 readthrough (RPL17-C18orf32)

Target
RPL17-C18orf32
Molecular classification
Other (Chimeric readthrough gene product), Ribosomal protein (mainly aligns with properties of RPL17)
01

Overview

The RPL17-C18orf32 readthrough is a product of natural readthrough transcription between the human RPL17 gene, which encodes a component of the 60S ribosomal subunit, and the adjacent C18orf32 gene. The resulting transcripts encode proteins that incorporate most of the RPL17 sequence but terminate with a distinct, frameshifted C-terminal extension derived from C18orf32 exons. While RPL17 is essential for ribosomal assembly and protein translation, and its mutations are linked to disorders such as Diamond-Blackfan anemia, the physiological and pathological roles of the RPL17-C18orf32 chimeric product are largely uncharacterized and not currently targeted by therapeutics[3][4][5][2][1].

Other names
RPL17-C18orf32 proteinRPL17C18orf3260S ribosomal protein L17Large ribosomal subunit protein uL22
02

Biological functions

Structural constituent of ribosomeRibosome biogenesisProtein synthesis
03

Disease associations

Macrocytic anemia (described for RPL17-C18orf32)Ribosomopathies (relevant for RPL17)Stress vulnerability, mood disorders (for RPL17, not the readthrough specifically)

Beyond the preview

Go deeper on RPL17-C18orf32 readthrough (RPL17-C18orf32).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RPL17-C18orf32 readthrough (RPL17-C18orf32).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call